Clasificación en acciones
#24945
SomnoMed Limited, together with its subsidiaries, produce and sells devices for... SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient’s mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient’s upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
Precio por acción
$0.2503761
Capitalización bursátil
$55.02M
Comercio SomnoMed Limited (SOM)
Precio SOM con Capital del mercado a B
Capitalización de mercado de SomnoMed Limited(SOM)
Capitalización bursátil: $55.02M
A fecha de August 2026, SomnoMed Limited tiene una capitalización de mercado de $55.02M. Esto convierte a SomnoMed Limited en la 24945th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de SomnoMed Limited desde 2020 hasta 2026
SOM en comparación con los más populares 5 títulos stocks
| Precio por SOM |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.257T
|
+9,553,444.14%
|
|
|
|
|
$4.599T
|
+8,357,264.77%
|
|
|
|
|
$4.107T
|
+7,463,002.94%
|
|
|
|
|
$3.577T
|
+6,501,024.93%
|
|
|
|
|
$2.807T
|
+5,101,759.10%
|
